OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
At a summit between one of Russia’s leading inventors and the country’s top cardiologist, a curious parallel emerged. Microelectronics specialist Martyn Nunuparov wanted to produce a pacemaker that requires no battery, but he had little knowledge...
HELSINKI, Finland - The Skolkovo stand at Slush 2014 featured so many resident companies that they weren’t all able to exhibit their innovations simultaneously. A handful of the total 51 startups – out to woo the wealthy investors milling around...